Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Cost-effectiveness of implantable cardioverter-defibrillator in today's world.

Boriani G, Cimaglia P, Biffi M, Martignani C, Ziacchi M, Valzania C, Diemberger I.

Indian Heart J. 2014 Jan-Feb;66 Suppl 1:S101-4. doi: 10.1016/j.ihj.2013.12.034. Review.

2.

Informed consent in cardiac resynchronization therapy: what should be said?

Kramer DB, Brock DW, Tedrow UB.

Circ Cardiovasc Qual Outcomes. 2011 Sep;4(5):573-7. doi: 10.1161/CIRCOUTCOMES.111.961680. Review. No abstract available.

3.

Sudden cardiac death risk prediction: comment on "Risk factor and prediction modeling for sudden cardiac death in women with coronary artery disease".

Albert CM.

Arch Intern Med. 2011 Oct 24;171(19):1710-1. doi: 10.1001/archinternmed.2011.363. No abstract available.

4.

Implantable cardioverter defibrillator therapy: a single center experience in saudi arabia.

Hersi AS.

Open Cardiovasc Med J. 2010 Sep 28;4:192-7. doi: 10.2174/1874192401004010192.

5.

Prediction of sudden cardiac death in patients with coronary heart disease: the challenge ahead.

Albert CM.

Circ Cardiovasc Imaging. 2008 Nov;1(3):175-7. doi: 10.1161/CIRCIMAGING.108.825588. No abstract available.

6.

Genetic association studies of sudden cardiac death/arrest: the importance of context.

Tseng ZH.

Heart Rhythm. 2009 Sep;6(9):1315-7. doi: 10.1016/j.hrthm.2009.06.034. No abstract available.

7.

Device therapy in heart failure.

McAlister FA.

BMJ. 2007 Nov 3;335(7626):895-6. No abstract available.

Items per page

Supplemental Content

Support Center